[HTML][HTML] Epidemiology of environmental exposure and malignant mesothelioma

B Liu, M van Gerwen, S Bonassi, E Taioli - Journal of Thoracic Oncology, 2017 - Elsevier
Although the association between exposure to asbestos and malignant mesothelioma
(particularly malignant pleural mesothelioma) has been well established, the health impact …

Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma.

H Kaya, C Sezgı, AC Tanrıkulu, M Taylan, O Abakay… - Neoplasma, 2014 - europepmc.org
Malignant mesothelioma is a rare but highly lethal form of cancer that affects the serosal
membranes. Malignant peritoneal mesothelioma (MPM) is the second most common form of …

Fibulin-3 as a diagnostic biomarker in patients with malignant mesothelioma

H Kaya, M Demir, M Taylan, C Sezgi… - Asian Pacific Journal …, 2015 - koreascience.kr
Background: New tumour biomarkers are being intensely investigated for malignant
mesothelioma (MM). Fibulin-3 is produced in MM but its role remains uncertain. The aim of …

Symptom burden in mesothelioma patients admitted to home palliative care

S Mercadante, D Degiovanni… - Current medical research …, 2016 - Taylor & Francis
Context: Mesothelioma is a very aggressive cancer that is brought on by asbestos exposure.
Because there is a long latency period between exposure to asbestos and symptoms of …

Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study)

C Raynaud, L Greillier, J Mazieres, I Monnet… - BMC cancer, 2015 - Springer
Background Malignant pleural mesothelioma (MPM) is a rare disease with poor prognosis in
spite of significant improvement in survival, due to new chemotherapy regimens. We …

Relationship between prognosis and neutrophil: lymphocyte and platelet: lymphocyte ratios in patients with malignant pleural mesotheliomas

YB Cihan, A Ozturk, H Mutlu - Asian Pacific Journal of Cancer …, 2014 - koreascience.kr
Background: It has been demonstrated that neutrophil: lymphocyte (NLR) and platelet:
lymphocyte (PLR) ratios are associated with prognosis in cancer patients. The aim of this …

Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma

K Goricar, V Kovac, V Dolzan - Radiology and oncology, 2014 - sciendo.com
Malignant pleural mesothelioma (MPM) is a rare but aggressive tumour of mesothelial
surfaces of pleura that is mainly connected with asbestos exposure. 1 Most patients are …

Prognostic factors in malignant pleural mesothelioma: a retrospective study of 60 Turkish patients

A Koyuncu, D Koksal, O Ozmen… - Journal of cancer …, 2015 - journals.lww.com
Aim: Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor prognosis.
The study aims to examine the effect of certain clinical, laboratory, radiologic, and pathologic …

Incidental finding of a malignant tumour in an inguinal hernia sac

R Qin, Q Zhang, J Weng, Y Pu - Contemporary Oncology/Współczesna …, 2014 - termedia.pl
Metastatic carcinomas in hernial sacs are rare, especially in bilateral femoral hernias. Here
we describe a 63-yearold female patient with metastatic carcinoma in bilateral femoral …

Non-asbestos-related malignant pleural mesothelioma

A Kanbay, ZO Simsek, N Tutar, I Yilmaz… - Internal …, 2014 - jstage.jst.go.jp
Malignant pleural mesothelioma (MPM) is an uncommon tumor derived from mesothelial
lining cells. MPM has been described as an insidious neoplasm because of its long latency …